Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.61B |
| 2 |
Microsoft
MSFT
|
+$1.17B |
| 3 |
Broadcom
AVGO
|
+$366M |
| 4 |
Merck
MRK
|
+$343M |
| 5 |
Meta Platforms (Facebook)
META
|
+$260M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$609M |
| 2 |
CMA
Comerica
CMA
|
+$512M |
| 3 |
CADE
Cadence Bank
CADE
|
+$422M |
| 4 |
Johnson & Johnson
JNJ
|
+$331M |
| 5 |
Western Digital
WDC
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.81% |
| 2 | Financials | 17.07% |
| 3 | Industrials | 12.54% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Healthcare | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Ironwood Pharmaceuticals
IRWD
$644M
| $7.31M | ﹤0.01% |
2,082,055
+1,751,219
| +529% | +$7.18M |
|
|
SEMR
2377
DELISTED
Semrush
SEMR
| $7.29M | ﹤0.01% |
610,889
-614,078
| -50% | -$7.3M |
|
2378
Hertz
HTZ
$632M
| $7.27M | ﹤0.01% |
1,577,908
-80,798
| -5% | -$391K |
|
|
CSGS
2379
DELISTED
CSG Systems International
CSGS
| $7.26M | ﹤0.01% |
90,868
-649,438
| -88% | -$51.7M |
|
2380
Ericsson
ERIC
$31.8B
| $7.2M | ﹤0.01% |
639,045
+19,334
| +3% | +$209K |
|
2381
Helen of Troy
HELE
$658M
| $7.19M | ﹤0.01% |
498,745
-201,859
| -29% | -$3.53M |
|
2382
Community Health Systems
CYH
$383M
| $7.18M | ﹤0.01% |
2,443,618
+118,946
| +5% | +$385K |
|
2383
American Outdoor Brands
AOUT
$158M
| $7.16M | ﹤0.01% |
766,388
-10,930
| -1% | -$96.7K |
|
2384
Red Violet
RDVT
$889M
| $7.15M | ﹤0.01% |
206,698
+32,189
| +18% | +$1.42M |
|
2385
International Money Express
IMXI
$386M
| $7.12M | ﹤0.01% |
450,637
-238,537
| -35% | -$3.73M |
|
2386
Rubrik
RBRK
$15.4B
| $7.09M | ﹤0.01% |
144,761
-245,339
| -63% | -$14.1M |
|
|
OKLO
2387
Oklo
OKLO
$7.27B
| $7.05M | ﹤0.01% |
142,482
-78,179
| -35% | -$5.62M |
|
|
RAPP
2388
Rapport Therapeutics
RAPP
$2.01B
| $7.02M | ﹤0.01% |
224,498
+141,011
| +169% | +$3.97M |
|
2389
Xometry
XMTR
$4.75B
| $7M | ﹤0.01% |
171,504
-64,728
| -27% | -$3.44M |
|
2390
Vertex
VERX
$2.05B
| $6.92M | ﹤0.01% |
582,427
-235,818
| -29% | -$3.67M |
|
2391
Groupon
GRPN
$1.05B
| $6.91M | ﹤0.01% |
580,873
+128,097
| +28% | +$1.71M |
|
2392
Solid Biosciences
SLDB
$777M
| $6.88M | ﹤0.01% |
956,135
+277,051
| +41% | +$1.78M |
|
2393
Citizens Community Bancorp
CZWI
$206M
| $6.87M | ﹤0.01% |
346,741
+10,515
| +3% | +$193K |
|
2394
Organogenesis Holdings
ORGO
$328M
| $6.85M | ﹤0.01% |
2,891,006
+160,026
| +6% | +$554K |
|
2395
Personalis
PSNL
$1.28B
| $6.79M | ﹤0.01% |
1,066,248
+83,074
| +8% | +$701K |
|
2396
Digital Turbine
APPS
$1.04B
| $6.78M | ﹤0.01% |
2,353,594
+846,116
| +56% | +$3.63M |
|
2397
Choiceone Financial
COFS
$507M
| $6.76M | ﹤0.01% |
240,425
+37,514
| +18% | +$1.08M |
|
|
SRTA
2398
Strata Critical Medical Inc
SRTA
$445M
| $6.76M | ﹤0.01% |
1,617,104
+172,154
| +12% | +$829K |
|
2399
Atea Pharmaceuticals
AVIR
$386M
| $6.75M | ﹤0.01% |
1,255,484
-118,462
| -9% | -$544K |
|
|
CRON
2400
Cronos Group
CRON
$1.07B
| $6.72M | ﹤0.01% |
2,679,051
+172,841
| +7% | +$450K |
|
Similar funds
Dimensional Fund Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Dimensional Fund Advisors held 3,312 positions worth $481B, up 0.98% from $477B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q1 2026 filing shows 72 new, 1,935 increased, 1,135 reduced and 97 closed positions. Its largest new stake was Versant Media Group: 1,127,961 shares worth $41.7M. The largest sale was AstraZeneca, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2026 buy was Versant Media Group: 1,127,961 shares worth $41.7M.
- Dimensional Fund Advisors added most to Amazon in Q1 2026, an estimated $1.61B increase.
- Dimensional Fund Advisors's biggest Q1 2026 reduction was Johnson & Johnson, cutting an estimated $331M.
- Dimensional Fund Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $609M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $481B portfolio in Q1 2026.
- Dimensional Fund Advisors opened 72 new positions and closed 97 in Q1 2026.
- Dimensional Fund Advisors's portfolio value rose 0.98% quarter-over-quarter to $481B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.